BOPPY-based novel fluorescent dopamine D2 and D3 receptor ligands

被引：9
|
作者：
Elek, Milica [1 ]
Dubiel, Mariam [1 ]
Mayer, Laura [2 ]
Zivkovic, Aleksandra [1 ]
Mueller, Thomas J. J. [2 ]
Stark, Holger [1 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Organ Chem, Univ Str 1, D-40225 Dusseldorf, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2022年 / 59卷
关键词：
Dopamine; BOPPY; D2R; D3R; Fluorescence; Ligands; HIGHLY FLUORESCENT; HIGH-AFFINITY; BODIPY DYES; D3; SCHIZOPHRENIA; BIOLOGY; BINDING; PROBES; TARGET;
D O I：
10.1016/j.bmcl.2022.128573
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Dopamine is one of the crucial neurotransmitters in the human brain. Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D-2 and D-3 receptor subtypes. Although BODIPY is a highly versatile structural moiety for fluorescence labeling, we have looked out for structurally related pyridine-based moieties. We used BOPPY labelling of well-described D2R/D3R pharmacophores to obtain ligands with moderate to low nanomolar binding affinities as well as low to excellent quantum yields for bright fluorescence ligands. To best of our knowledge, this is the first report on the application of BOPPY fluorophores to GPCR ligands. This approach offers a general applicable way for fluorescence labelling via primary aliphatic amine elements.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Fluorescent ligands for dopamine D2/D3 receptors
    Allikalt, Anni
    Purkayastha, Nirupam
    Flad, Khajidmaa
    Schmidt, Maximilian F.
    Tabor, Alina
    Gmeiner, Peter
    Huebner, Harald
    Weikert, Dorothee
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
    Elek, Milica
    Djokovic, Nemanja
    Frank, Annika
    Oljacic, Slavica
    Zivkovic, Aleksandra
    Nikolic, Katarina
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2021, 354 (06)
  • [3] Aromatic linker variations in novel dopamine D2 and D3 receptor ligands
    Di Biase, Cristian
    Leitzbach, Luisa
    Frank, Annika
    Zivkovic, Aleksandra
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2024, 357 (08)
  • [4] Novel Bivalent Ligands for D2/D3 Dopamine Receptors: Significant Cooperative Gain in D2 Affinity and Potency
    Gogoi, Sanjib
    Biswas, Swati
    Modi, Gyan
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 991 - 996
  • [5] Synthesis of bitopic ligands based on fallypride and evaluation of their affinity and selectivity towards dopamine D2 and D3 receptors
    Tian, Gui-Long
    Hsieh, Chia-Ju
    Taylor, Michelle
    Riad, Aladdin A.
    Luedtke, Robert R.
    Mach, Robert H.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261
  • [6] Design, Synthesis, and Evaluation of Indolebutylamines as a Novel Class of Selective Dopamine D3 Receptor Ligands
    Du, Peng
    Xu, Lili
    Huang, Jiye
    Yu, Kunqian
    Zhao, Rui
    Gao, Bo
    Jiang, Hualiang
    Zhao, Weili
    Zhen, Xuechu
    Fu, Wei
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (03) : 326 - 335
  • [7] Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor
    Yarkov, Alex V.
    Der, Terry C.
    Joyce, Jeffrey N.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 167 - 172
  • [8] Transient equilibrium determination of dopamine D2/D3 receptor densities and affinities in brain
    Phan, Jenny-Ann
    Wong, Dean F.
    Chang, Natalie H. S.
    Kumakura, Yoshitaka
    Bauer, William R.
    Gjedde, Albert
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 2
  • [9] Functionally Selective Dopamine D2, D3 Receptor Partial Agonists
    Moeller, Dorothee
    Kling, Ralf C.
    Skultety, Marika
    Leuner, Kristina
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4861 - 4875
  • [10] Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
    Kiss, Bela
    Horvath, Attila
    Nemethy, Zsolt
    Schmidt, Eva
    Laszlovszky, Istvan
    Bugovics, Gyula
    Fazekas, Karoly
    Hornok, Katalin
    Orosz, Szabolcs
    Gyertyan, Istvan
    Agai-Csongor, Eva
    Domany, Gyoergy
    Tihanyi, Karoly
    Adham, Nika
    Szombathelyi, Zsolt
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01) : 328 - 340
12345